ATE6590T1 - Verwendung von ophthalmischen zusammensetzungen, die einen plasminogenaktivator enthalten, zur reinigung von kontaktlinsen. - Google Patents

Verwendung von ophthalmischen zusammensetzungen, die einen plasminogenaktivator enthalten, zur reinigung von kontaktlinsen.

Info

Publication number
ATE6590T1
ATE6590T1 AT81400853T AT81400853T ATE6590T1 AT E6590 T1 ATE6590 T1 AT E6590T1 AT 81400853 T AT81400853 T AT 81400853T AT 81400853 T AT81400853 T AT 81400853T AT E6590 T1 ATE6590 T1 AT E6590T1
Authority
AT
Austria
Prior art keywords
contact lenses
plasminogen activator
compositions containing
ophthalmic compositions
cleaning contact
Prior art date
Application number
AT81400853T
Other languages
German (de)
English (en)
Inventor
Lucien Dussourd D'hinterland
Gerard Normier
Original Assignee
Pierre Fabre S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre S.A. filed Critical Pierre Fabre S.A.
Application granted granted Critical
Publication of ATE6590T1 publication Critical patent/ATE6590T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/082—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances in combination with specific enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Eyeglasses (AREA)
  • Detergent Compositions (AREA)
AT81400853T 1980-05-29 1981-05-27 Verwendung von ophthalmischen zusammensetzungen, die einen plasminogenaktivator enthalten, zur reinigung von kontaktlinsen. ATE6590T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8011911A FR2483234A2 (fr) 1980-05-29 1980-05-29 Composition ophtalmique contenant un activateur du plasminogene
EP81400853A EP0041449B1 (fr) 1980-05-29 1981-05-27 Application d'une composition ophtalmique contenant un activateur du plasminogène, au nettoyage des lentilles cornéennes

Publications (1)

Publication Number Publication Date
ATE6590T1 true ATE6590T1 (de) 1984-03-15

Family

ID=9242458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81400853T ATE6590T1 (de) 1980-05-29 1981-05-27 Verwendung von ophthalmischen zusammensetzungen, die einen plasminogenaktivator enthalten, zur reinigung von kontaktlinsen.

Country Status (4)

Country Link
EP (1) EP0041449B1 (OSRAM)
AT (1) ATE6590T1 (OSRAM)
DE (1) DE3162616D1 (OSRAM)
FR (1) FR2483234A2 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
ZA869434B (en) * 1985-12-16 1988-07-27 Ethicon Inc Method for inhibiting post-surgical adhesion formation by the topical administration of tussue plasminogen activator
CA1336396C (en) * 1988-07-25 1995-07-25 Kiyoshi Kita Intraocular anticoagulant including antithrombin iii and method of administration
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
DE19606551C2 (de) * 1996-02-22 2000-06-08 Basotherm Gmbh rt-PA zur Prävention des Nachstars nach Kataraktoperation
WO1997031660A1 (en) * 1996-02-29 1997-09-04 Vision Pharmaceuticals L.P. Contact lens treating compositions, methods of treatment, and novel lenses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872146A (en) * 1958-01-06 1961-07-05 Innerfield Irving Emzymic composition
US3324002A (en) * 1962-09-17 1967-06-06 Armour Pharma Anti-inflammatory preparations containing proteolytic enzymes and adrenal glucocorticoids
US3910296A (en) * 1973-04-20 1975-10-07 Allergan Pharma Method of removing proteinaceous deposits from contact lenses
FR2252842B1 (OSRAM) * 1973-12-03 1977-11-04 Fabre Sa Pierre
FR2462165A2 (fr) * 1973-12-03 1981-02-13 Fabre Sa Pierre Procede perfectionne de preparation d'activateur du plasminogene
FR2310133A2 (fr) * 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne
CA1154671A (fr) * 1979-07-27 1983-10-04 Lucien D. D'hinterland Separation d'un activateur tissulaire du plasminogene

Also Published As

Publication number Publication date
EP0041449A1 (fr) 1981-12-09
EP0041449B1 (fr) 1984-03-14
FR2483234B2 (OSRAM) 1983-12-23
FR2483234A2 (fr) 1981-12-04
DE3162616D1 (en) 1984-04-19

Similar Documents

Publication Publication Date Title
NL950006I1 (nl) Gesubstitueerde aromatische sulfonamiden als antiglaucoom-middelen.
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
CA2070286A1 (en) Non Oxidative Ophthalmic Compositions and Methods for Preserving and Using Same
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
DE3568431D1 (en) Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
DE3583013D1 (de) Squarilium-verbindungen und fluessigkristallzusammensetzungen, die diese enthalten.
DE3162128D1 (en) Biologically active compounds, their obtention from human casein and compositions containing them
ATE6590T1 (de) Verwendung von ophthalmischen zusammensetzungen, die einen plasminogenaktivator enthalten, zur reinigung von kontaktlinsen.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
ATE187599T1 (de) Verwendung von amidoamine in ophtalmischen zusammensetzungen
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
DE69229688D1 (de) Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten
ATE46817T1 (de) Verwendung von 6-(z)- bzw. 2-(z)-konfigurierten 3,7,11-trimethyl-dodeca-2,6,10-trien-1-olen als bakteriostatikum in kosmetischen produkten.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE78395T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
ATE148344T1 (de) Verwendung von 15-dehydroxy-16-oxoprostaglandin bei der behandlung von allergischen erkrankungen
BG43523A3 (en) Means for growth regulation of plants
DE3880066D1 (de) Optisch aktive fluessigkristallverbindungen und zusammensetzungen, die diese enthalten.
ATE6124T1 (de) Arzneimittel zur lokalen behandlung des glaukoms.
DE3579476D1 (de) Haarwuchsstimulierende mittel und deren verwendung.
FI903787A7 (fi) Desinficerings- och avspulningsvaetskan foer kontaktlinser och dess anvaendning.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee